Health Care Providers & Services · NYSE

DGXQuest Diagnostics Inc

Last close
$259.60 -0.0%
52-week range
$171.18 to $262.00
Market cap
$28.6B
Next earnings
Not scheduled

Fiscal 2025 at a glance

Revenue
$11.0B
+12% vs FY24
Net income
$992M
+14% vs FY24
Free cash flow
$1.36B
+50% vs FY24
Net cash
-$5.25B
Cash $420M, debt $5.67B

Stock price

+185% since Dec 2016

Valuation vs its own 10 years

Above its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
25.9x
7.9x25.9x
Highest point in its range, above its median of 18.7x
Price / sales
2.4x
1.4x2.4x
Highest point in its range, above its median of 1.8x
EV / EBITDA
14.4x
6.5x14.4x
Highest point in its range, above its median of 11.5x
Price / free cash flow
20.8x
7.7x23.3x
98th percentile, above its median of 15.8x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
25.9x
Earnings yield
3.9%
Price / sales
2.4x
Price / book
3.7x
Price / operating cash flow
14.6x
EV / EBITDA
14.4x
EV / sales
2.8x
Free cash flow yield
4.8%

Profitability

Gross margin
33.1%
Operating margin
14.6%
Net margin
9.5%
Return on equity
14.8%
Return on capital
10.1%

Growth per year

Revenue, 3 years
+3.7%
Revenue, 5 years
+3.2%
Revenue, 9 years
+4.8%
EPS, 3 years
+3.2%

Balance sheet

Cash and investments
$797M
Total debt
$5.55B
Net cash
-$4.75B
Debt / equity
0.73x
Current ratio
1.70x

Shares and dividend

Shares outstanding
110M
Share count, 5 years
-16.9%
Beta, 1 year
-0.06
Dividend yield
1.3%
Dividend per share, TTM
$3.38
Payout ratio
32.7%

Ten years of the business

Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $3.10B
RevenueNet income
Gross profitLatest quarter $1.04B
EBITDALatest quarter $626M
Margins34 / 15 / 10%
GrossOperatingNet
Earnings per shareLatest quarter $2.78
Cash flowLatest quarter $611M
OperatingCapexFree
Cash vs debtLatest quarter $797M
Cash and investmentsTotal debt
P/E historyNow 25.9x
P/E, median 18.7x dashed
P/S historyNow 2.4x
P/S, median 1.8x dashed

Where the revenue comes from

All Other Segments went from 3% to 2% of revenue in 3 years

Share of revenue by business segment, fiscal 2022 to 2025, as reported in the 10-K.

Diagnostic Information Services BusinessAll Other Segments
FY22
97%
$9.88B
FY23
97%
$9.25B
FY24
97%
$9.87B
FY25
98%
$11.0B
Fiscal 2025 by business segment
Business segmentRevenueSharevs FY24
Diagnostic Information Services Business$10.8B97.7%+12%
All Other Segments$250M2.3%-3%

Health Care Providers & Services peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
UNH Unitedhealth Group Inc $365B +3% 5.3%23.3x0.8x 68th percentile
MCK Mckesson Corp $127B +8% 1.6%28.4x0.3x 78th percentile
CVS CVS HEALTH Corp $114B +7% 3.6%10.4x0.3x 10th percentile
HCA HCA Healthcare, Inc. $104B +6% n/a16.5x1.3x 95th percentile
ELV Elevance Health, Inc. $92.8B +4% 2.7%18.3x0.5x 70th percentile
DGX Quest Diagnostics Inc $28.6B +9% 14.5%25.9x2.4x Highest in its range

The company

Sector
Health Care
Industry
Health Care Providers & Services
CEO
Steve Rusckowski
Founded
1967
Headquarters
Secaucus, NJ
Fiscal year ends
December
Website
questdiagnostics.com

What it does

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about DGX.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 815 active funds. Crowd level: crowd building, 10 rising quarters.

Open the Smart money tab